A novel 1565 nm non-ablative fractional device for stretch marks: A preliminary report

Abstract

Background: Striae Distensae (SD) is a very common dermatologic condition. We evaluated the effectiveness and safety of a novel non-ablative fractional 1565 nm laser (ResurFX) on the appearance of SD. Materials and methods: Twelve Caucasian subjects with various stages of SD received three non-ablative laser treatments. Each treatment consisted of two different laser settings, in order to achieve a demarcated dense impact together with a diffused deep impact. Three months after the last treatment, SD improvement was assessed by blinded and non-blinded reviewers using clinical images and 3D image analyses. Results: Good clinical improvement (between 51% and 75%) was observed in all patients. Most patients showed improvement of > 50% in the volume of depressions and in lesion color (91.7% and 83.3% of patients, respectively). The average pain during treatment was generally defined as tolerable and the average downtime was 4 days. Transient erythema and severe edema were noted immediately after the procedure, but long-lasting or severe adverse effects were not observed. All patients noted a good improvement and were satisfied with the treatment and the results. Conclusions: The treatment with the 1565 nm ResurFX laser resulted in improved pigmentation, volume, and textural appearance of SD.

Evaluation of a non‐ablative, fractional 1565 nm laser for the improvement of striae distensae albae

“…Clementoni et al . recently used a non‐ablative fractional 1565 nm laser for the treatment of SD rubrae and albae with little to no negative effects.…”

“…Most effective in the therapy of mature striae appear to be fractional lasers, with non‐ablative approaches delivering the most consistent results . A pilot study could demonstrate promising results in the therapy of SD rubrae and albae using a fractional, non‐ablative 1565 nm Er: glass laser …”

“…13,[23][24][25] A pilot study could demonstrate promising results in the therapy of SD rubrae and albae using a fractional, non-ablative 1565 nm Er: glass laser. 26 Although SD are categorized as a subtype of atrophic scarring, SD are not mentioned in current therapeutic guidelines for pathological scarring. [27][28][29] With recent data highlighting the potential of fractional lasers as an effective treatment tool for the improvement of SD, 26 we aimed to reassess the safety and effectiveness of fractional, non-ablative 1565 nm laser therapy by new objective and subjective assessment tools.…”

Wrinkle and roughness measurement by the Antera 3D and its application for evaluation of cosmetic products

“…Work demonstrating the Antera 3D capabilities at measuring benefits from various aesthetic intervention/dermatologic treatments for wrinkles, skin roughness, haemoglobin content, striae distensae have been published in the past few years, yet to our knowledge no effects from cosmetic products have been reported.…”

Safety and patient subjective efficacy of using galvanopuncture for the treatment of striae distensae

“…The treatment of striae distensae has included many therapeutic modalities . However, successful treatment has been disappointing for striae alba .…”